Tapering and withdrawal of tocilizumab in patients with systemic juvenile idiopathic arthritis in inactive disease: results from an alternative dosing regimen in the TENDER study

Detalles Bibliográficos
Autores principales: De Benedetti, F, Ruperto, N, Brunner, H, Grom, A, Wulffraat, N, Henrickson, M, Jerath, R, Kimura, Y, Kadva, AK, Wang, J, Martini, A, Lovell, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184132/
http://dx.doi.org/10.1186/1546-0096-12-S1-O13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184132/
http://dx.doi.org/10.1186/1546-0096-12-S1-O13

Ejemplares similares